Furthermore, we observed that CNOT3 expression is elevated in the majority of assayed AML patient samples (10 out of 12) by immunoblot compared to normal human cord blood CD34+ cells (CB-CD34+ cells) (Fig. 1B and Supplementary Fig. 1C and Supplemental dataset 1). This evidence concerns the gene CNOT3 and acute myeloid leukemia.